Stocktoria

Celcuity Inc. CELC

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2017-09-20 · LEI

Celcuity Inc. statistics & valuation

Market cap$4.9B
P / B48.5×
Return on equity-176.1%
Net cash$28.2M
Enterprise value USD$4.8B
Earnings yield EBIT/EV-3.6%
Return on capital-40.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-59.00% -19.90% -29.50% -38.10% -81.00% -43.10% -30.20% -45.60% -96.70% -176.10% 2016201720182019202020212022202320242025
Shares outstanding
0 10.1M 10.2M 10.3M 10.3M 14.9M 21.7M 25.5M 39.4M 48.2M 2016201720182019202020212022202320242025
Net debt ($)
-$68.3M $11.2M $6.9M $82.6M -$28.2M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-54.70% -19.60% -28.70% -36.30% -73.10% -34.50% -23.00% -33.40% -45.60% -37.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
0.23× 0.27× 0.27× 0.91× 1.37× 2016201720182019202020212022202320242025
EPS ($)
-$2.64 -$2.69 -$2.83 -$3.79 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-37.9%-45.6%-33.4%-23.0%-34.5%-73.1%-36.3%-28.7%-19.6%-54.7%
Return on equity-176.1%-96.7%-45.6%-30.2%-43.1%-81.0%-38.1%-29.5%-19.9%-59.0%
Debt / equity1.37×0.91×0.27×0.27×0.23×—————
Current ratio10.557.7113.4325.4634.0610.2621.1238.0742.3613.27

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.